Biodexa Pharmaceticals share price logo

Biodexa Pharmaceticals Share Price

NASDAQ: BDRX

Small Cap

$3.48

+0.01

(+0.29%)

as on

Biodexa Pharmaceticals Stock Performance

as on April 18, 2026 at 6:58 am IST

  • Day's Low

    $3.39
    $3.48
    downward going graph

    2.59%

    Downside

  • 52 Week's Low

    52 Week's High

    $2.86
    $96.50
    downward going graph

    17.82%

    Downside

    2672.99%

    Upside

    downward going graph

Biodexa Pharmaceticals share price movements today

Previous Close
$3.47
Open
$3.42
Volume
250.7K
Day's Low - High
$3.39 - $3.48
52 Week Low - High
$2.86 - $96.50

Biodexa Pharmaceticals Historical Returns

1 Month Return
-9.63 %
3 Month Return
-68.93 %
1 Year Return
-95.13 %
3 Year Return
-99.99 %
5 Year Return
0 %

Biodexa Pharmaceticals Stock Fundamentals & Key Indicators

Check Biodexa Pharmaceticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.3M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-8.6M

Revenue (TTM)

83.0K

Profit Margin

0.00%

Return On Equity TTM

-64.72%

Biodexa Pharmaceticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biodexa Pharmaceticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Biodexa Pharmaceticals image
Biodexa Pharmaceticals
BUY$2.3MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B122.97%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B101.1%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$37.2BNA131.655.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B49.34%17.9831.41%

Stock Returns calculator for Biodexa Pharmaceticals Stock including INR - Dollar returns

The Biodexa Pharmaceticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Biodexa Pharmaceticals investment value today

Current value as on today

₹5,273

Returns

-₹94,727

(-94.73%)

Returns from Biodexa Pharmaceticals Stock

-₹95,133 (-95.13%)

Dollar Impact

₹405 (+0.41%)

Analyst Recommendation on Biodexa Pharmaceticals Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Biodexa Pharmaceticals. Average target price of $35.87

Biodexa Pharmaceticals Share Price Target

Get share price movements and forecasts by analysts on Biodexa Pharmaceticals.

What analysts predicted

90.3%UPSIDE

Target Price

$35.87

Current Price

$3.48

Analyzed by

7 Analysts

Target

$35.87

Biodexa Pharmaceticals target price $35.87, a slight upside of 90.3% compared to current price of $3.48. According to 7 analysts rating.

Biodexa Pharmaceticals Stock’s Investor Sentiment and Interest

Investment in Biodexa Pharmaceticals Shares on INDmoney has grown by 440.74% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:440.74% versus previous 30 day period

Biodexa Pharmaceticals Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Total Revenue
0
0
0
0
0
Gross Profit
-3
-1
-2
-1
-2
Operating Income
-3
-2
-4
-1
-3
EBITDA
-3
-2
-4
-1
-2
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
-5
-1
-3
-1
-3
Income Tax Expense
0
0
0
0
0
Net Income
-5
-2
-4
-1
-3
Net Profit Margin
-1989.18%
-1197.32%
-1197.32%
-4230.12%
-4230.12%

Biodexa Pharmaceticals Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
1
0
0
0
0
0
-
-
Gross Profit
-6
-7
-7
-9
-7
-5
-5
-4
-6
0
Operating Income
-9
-11
-11
-11
-23
-6
-8
-8
-9
-8
EBITDA
-5
-10
-10
-9
-22
-5
-8
-7
-9
-8
Interest Expense
-
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
1
1
0
0
0
0
0
Income Before Tax
-8
-12
-12
-10
-23
-6
-8
-7
-5
-6
Income Tax Expense
-2
-1
-2
-1
-1
0
0
0
0
0
Net Income
-6
-11
-10
-13
-29
-7
-9
-8
-7
-6
Net Profit Margin
-465.68%
-1183.52%
-534.98%
-1496.29%
-6469.10%
-944.64%
-1095.28%
-1858.01%
0.00%
0.00%

Biodexa Pharmaceticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Net Income
-1
-3
-1
-3
-1
-3
-2
-3
-2
Operating Cash Flow
-1
-3
-1
-2
-2
-4
-7
-3
-2
Investing Cash Flow
0
0
-
0
-
0
0
0
0
Financing Cash Flow
3
6
1
3
2
4
3
6
7
Change in Cash
1
1
0
0
0
5
-5
4
4

Biodexa Pharmaceticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-15
-10
-22
-5
-7
-7
-5
-6
Operating Cash Flow
-12
-13
-6
-9
-6
-7
-6
-12
-5
Investing Cash Flow
-1
9
-3
2
0
0
0
0
0
Financing Cash Flow
10
-6
18
3
8
0
10
8
12
Change in Cash
-4
-10
8
-3
2
-7
3
-4
6

Insights on Biodexa Pharmaceticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 41.5K → 83.0K (in $), with an average increase of 50.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -3.80M → -2.56M (in $), with an average increase of 48.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 40.2% return, outperforming this stock by 135.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 125.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BDRX stock has moved down by -68.9%

About Biodexa Pharmaceticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of diffuse intrinsic recurrent glioblastoma, diffuse midline glioma, and medulloblastoma. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release therapeutics; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. It has collaboration agreements with Janssen and Melior. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
OrganisationBiodexa Pharmaceticals
Headquarters1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ
IndustryBiotechnology
CEOMr. Stephen Anthony Stamp
E-voting on sharesClick here to vote

Key Management of Biodexa Pharmaceticals

Name

Title

Mr. Steve Ellul

Chief Business Officer

Dr. Gary A. Shangold CPI, FACOG, M.D.

Chief Medical Officer

Ms. Noreen Bhatti

Vice President of Clinical Operations

Mr. Stephen Anthony Stamp

CEO & Director

Ms. Fiona Mary Powell

Company Secretary, CFO & Director

Dr. Daniel Palmer MBA, Ph.D.

Vice President of Technology

FAQs

What is Biodexa Pharmaceticals share price today?

Biodexa Pharmaceticals share price today is $3.48 as on at the close of the market. Biodexa Pharmaceticals share today touched a day high of $3.48 and a low of $3.39.

What is the 52 week high and 52 week low for Biodexa Pharmaceticals share?

Biodexa Pharmaceticals share touched a 52 week high of $96.5 on and a 52 week low of $2.86 on . Biodexa Pharmaceticals stock price today i.e. is closed at $3.48,which is 96.39% down from its 52 week high and 21.68% up from its 52 week low.

What is Biodexa Pharmaceticals's market capitalisation today?

Biodexa Pharmaceticals market capitalisation is $0.00T as on .

How to invest in Biodexa Pharmaceticals Stock (BDRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biodexa Pharmaceticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biodexa Pharmaceticals Shares that will get you 0.4310 shares as per Biodexa Pharmaceticals share price of $3.48 per share as on April 18, 2026 at 1:28 am IST.

What is the minimum amount required to buy Biodexa Pharmaceticals Stock (BDRX) from India?

Indian investors can start investing in Biodexa Pharmaceticals (BDRX) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Biodexa Pharmaceticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Biodexa Pharmaceticals share’s latest price of $3.48 as on April 18, 2026 at 1:28 am IST, you will get 2.8736 shares of Biodexa Pharmaceticals. Learn more about fractional shares .